{
  "version": "0.3.1",
  "atoms": [],
  "cards": [
    [
      "email",
      {
        "html": "<p>Good morning, {first_name, \"lovely subscriber\"},</p><p>Welcome to the very first edition of Morning Conference — the morning newsletter for subscribers of <em>One Man &amp; His Blog. </em>I had this idea late last year, but unfortunately, the closure of schools put pay to my plans to launch in January.</p><p>Here's the idea: this is a short, sharp morning email, to help you catch up on the media and publishing related news that might be useful to you in your work. I'll give you a little context on each story, and let you decide if it's relevant.</p><p>In a way, I'm giving you a glimpse into my “notebook”, at the sort of information I'm using to inform my training and consulting work.</p><p>Feedback, as ever, gratefully received.</p>"
      }
    ],
    [
      "bookmark",
      {
        "type": "bookmark",
        "url": "https://www.axios.com/facebook-paying-writers-journalists-pages-0b96d3cd-e61b-4435-9f54-99aed136f932.html",
        "metadata": {
          "url": "https://www.axios.com/facebook-paying-writers-journalists-pages-0b96d3cd-e61b-4435-9f54-99aed136f932.html",
          "title": "Facebook explores paid deals for new publishing platform",
          "description": "The company plans to build tools within the platform that allow writers to monetize.",
          "author": "Sara Fischer",
          "publisher": "Axios",
          "thumbnail": "https://images.axios.com/9HQ1rVFlGwoMnCqDS18hU_rDv4I=/0x0:1920x1080/1366x768/2021/03/15/1615845927047.jpg",
          "icon": "https://static.axios.com/img/axios-site/favicon-32x32.png"
        }
      }
    ],
    [
      "bookmark",
      {
        "url": "https://www.getrevue.co/profile/the_week_in_newsletters/issues/the-first-revue-creator-highlight-meet-matt-navarra-446370",
        "metadata": {
          "url": "https://www.getrevue.co/profile/the_week_in_newsletters/issues/the-first-revue-creator-highlight-meet-matt-navarra-446370",
          "title": "The first Revue Creator Highlight: Meet Matt Navarra",
          "description": "The week in newsletters -",
          "author": null,
          "publisher": "Revue",
          "thumbnail": "https://s3.amazonaws.com/revue/issue_images/images/000/192/216/original/issue_image_446370.jpg?1615904519",
          "icon": "https://d3jbm9h03wxzi9.cloudfront.net/assets/favicon-84fc7f228d52c2410eb7aa839e279caeaa491588c7c75229ed33e1c7f69fe75d.ico"
        }
      }
    ],
    [
      "bookmark",
      {
        "url": "https://www.theverge.com/2021/3/14/22330428/facebook-research-vaccine-hesitancy-doubt-coronavirus",
        "metadata": {
          "url": "https://www.theverge.com/2021/3/14/22330428/facebook-research-vaccine-hesitancy-doubt-coronavirus",
          "title": "Facebook research reportedly finds small number of users responsible for spreading vaccine doubt",
          "description": "According to a new report, Facebook research into “vaccine-hesitant beliefs” has found that a small group of users is driving many of the discussions that may sow doubt or discouragement about taking a vaccine.",
          "author": "Kim Lyons",
          "publisher": "The Verge",
          "thumbnail": "https://cdn.vox-cdn.com/thumbor/xeqGvpPdJorN2wEd0nWCOL9uKJ8=/0x146:2040x1214/fit-in/1200x630/cdn.vox-cdn.com/uploads/chorus_asset/file/10454933/mdoying_180118_2249_facebook_0445stills_3.jpg",
          "icon": "https://cdn.vox-cdn.com/uploads/chorus_asset/file/7395351/android-chrome-192x192.0.png"
        }
      }
    ],
    [
      "bookmark",
      {
        "url": "https://nextconf.eu/2021/03/apple-is-about-to-disrupt-the-attention-markets/",
        "metadata": {
          "url": "https://nextconf.eu/2021/03/apple-is-about-to-disrupt-the-attention-markets/",
          "title": "Attention market crashes and the coming ad reboot | NEXT Conference",
          "description": "Apple is about to change the way advertising works on the net forever. What does this mean for the future of attention markets?",
          "author": "Adam Tinworth",
          "publisher": "NEXT Conference",
          "thumbnail": "https://nextconf.eu/wp-content/uploads/2021/03/AttentionMarket-1024x576.png",
          "icon": "https://nextconf.eu/wp-content/uploads/2020/06/cropped-FAVICON_NEXT3-1-192x192.png"
        }
      }
    ],
    [
      "email",
      {
        "html": "<p><em>(You'll need to click through</em>)</p>"
      }
    ],
    [
      "embed",
      {
        "url": "https://twitter.com/bbcrosatkins/status/1371574236473561092?s=21",
        "html": "<blockquote class=\"twitter-tweet\"><p lang=\"en\" dir=\"ltr\">Things are getting complicated with the Astra Zeneca vaccine in Europe. Despite the  WHO saying it’s fine to use, Germany, France and others have suspended its use. We’ve looked at why and why some scientists are ‘baffled’. Produced <a href=\"https://twitter.com/MichaelCoxJ?ref_src=twsrc%5Etfw\">@michaelcoxJ</a> <a href=\"https://t.co/X1aeUdDabo\">https://t.co/X1aeUdDabo</a> <a href=\"https://t.co/NsugaLYN3R\">pic.twitter.com/NsugaLYN3R</a></p>&mdash; Ros Atkins (@BBCRosAtkins) <a href=\"https://twitter.com/BBCRosAtkins/status/1371574236473561092?ref_src=twsrc%5Etfw\">March 15, 2021</a></blockquote>\n<script async src=\"https://platform.twitter.com/widgets.js\" charset=\"utf-8\"></script>\n",
        "type": "rich",
        "metadata": {
          "url": "https://twitter.com/BBCRosAtkins/status/1371574236473561092",
          "author_name": "Ros Atkins",
          "author_url": "https://twitter.com/BBCRosAtkins",
          "width": 550,
          "height": null,
          "cache_age": "3153600000",
          "provider_name": "Twitter",
          "provider_url": "http://www.twitter.com/",
          "version": "1.0"
        }
      }
    ]
  ],
  "markups": [
    [
      "a",
      [
        "href",
        "https://www.facebook.com/formedia/supporting-independent-voices"
      ]
    ]
  ],
  "sections": [
    [
      10,
      0
    ],
    [
      1,
      "h2",
      [
        [
          0,
          [],
          0,
          "Enter FaceStack"
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "Substack and newsletters become a big thing, so clearly the Zuckercopier has been fired up to clone the product. Facebook has provided "
        ],
        [
          0,
          [
            0
          ],
          1,
          "a little more detail"
        ],
        [
          0,
          [],
          0,
          " on its forthcoming newsletter/creator monetisation offering. "
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "While I can see why Facebook is doing this, and why it might seem like an attractive idea to do this from some creators' point of view, the idea of the whole — or even a substantial chunk — of my income being dependent on Facebook's good will brings me out in hives. "
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "I see no sign here that Facebook will make it easy to move your subscribers, and their billing details, if you ever moved platform. Risky. "
        ]
      ]
    ],
    [
      10,
      1
    ],
    [
      1,
      "h2",
      [
        [
          0,
          [],
          0,
          "From $0 to $140,000 newsletter revenue in a year"
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "Talking of newsletter revenue, bloody hell, look at this:"
        ]
      ]
    ],
    [
      1,
      "blockquote",
      [
        [
          0,
          [],
          0,
          "Geekout was launched in June 2020 (nine months ago). It’s now on track to generate $140,000 in sponsorship and ad revenue in its first year."
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "There's two people working on it. That's a pretty lucrative side-hustle. Interesting that the revenue is ad-based: looks like social media managers are a spendy market to target. "
        ]
      ]
    ],
    [
      10,
      2
    ],
    [
      1,
      "h2",
      [
        [
          0,
          [],
          0,
          "Misinformation Watch: anti-vaxxers"
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "Once again, we see that social media — and Facebook in particular — can allow a small group of people to have an outsize impact on public discourse. "
        ]
      ]
    ],
    [
      10,
      3
    ],
    [
      1,
      "h2",
      [
        [
          0,
          [],
          0,
          "The coming ad market apocalypse"
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "OK, this is a bit of a cheeky one. This is a piece by me, for my long term client NEXT Conference. It thinks through some possible implications for targeted advertising from the next big iOS update. "
        ]
      ]
    ],
    [
      10,
      4
    ],
    [
      1,
      "h2",
      [
        [
          0,
          [],
          0,
          "The Astra Zeneca vaccine issue, explained"
        ]
      ]
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "This really is a masterclass in a short, useful video explainers:"
        ]
      ]
    ],
    [
      10,
      5
    ],
    [
      10,
      6
    ],
    [
      1,
      "p",
      [
        [
          0,
          [],
          0,
          "I never thought I'd say this, but I can't wait to have a needle jabbed in my arm…"
        ]
      ]
    ],
    [
      1,
      "p",
      []
    ]
  ],
  "ghostVersion": "4.0"
}